| 51 |
27659012 | Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells. | 2016 Sep |
2 |
| 52 |
27751820 | Inhibition of JNK and prothymosin-alpha sensitizes hepatocellular carcinoma cells to cisplatin. | 2016 Dec 15 |
4 |
| 53 |
27779694 | Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells. | 2016 Dec |
1 |
| 54 |
27825085 | AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1. IMPLICATION OF AKT2 IN CHEMORESISTANCE. | 2016 Oct 21 |
1 |
| 55 |
28101169 | Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer. | 2016 Dec |
1 |
| 56 |
25351964 | Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells. | 2015 Jan |
1 |
| 57 |
25563368 | FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway. | 2015 |
3 |
| 58 |
25682199 | Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis. | 2015 Jan 30 |
1 |
| 59 |
25793618 | Alpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1. | 2015 |
1 |
| 60 |
26049416 | APC selectively mediates response to chemotherapeutic agents in breast cancer. | 2015 Jun 7 |
1 |
| 61 |
26118633 | Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways. | 2015 Sep |
1 |
| 62 |
26592553 | MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma. | 2015 Nov 23 |
4 |
| 63 |
23543357 | Apoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cells. | 2014 Aug |
2 |
| 64 |
23584473 | PKA/Smurf1 signaling-mediated stabilization of Nur77 is required for anticancer drug cisplatin-induced apoptosis. | 2014 Mar 27 |
1 |
| 65 |
24675421 | Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition. | 2014 Mar 15 |
5 |
| 66 |
24686174 | E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin. | 2014 Apr 15 |
4 |
| 67 |
24865582 | Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway. | 2014 |
3 |
| 68 |
25006835 | Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin. | 2014 Jul 8 |
1 |
| 69 |
25028967 | Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells. | 2014 |
1 |
| 70 |
25152024 | Mig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathways. | 2014 Sep |
2 |
| 71 |
23103562 | TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. | 2013 Jan 15 |
3 |
| 72 |
23720056 | TR3 modulates platinum resistance in ovarian cancer. | 2013 Aug 1 |
2 |
| 73 |
23817665 | β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK. | 2013 Sep |
2 |
| 74 |
23886095 | [Thrichosanthin enhances cisplatin-induced laryngocarcinoma apoptosis through inhibiting transcription factor nuclear factor κB]. | 2013 Apr |
3 |
| 75 |
23900581 | Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA. | 2013 Oct |
3 |
| 76 |
23929259 | Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy. | 2013 Nov |
1 |
| 77 |
24055030 | MUC1 activates JNK1 and inhibits apoptosis under genotoxic stress. | 2013 Oct 11 |
2 |
| 78 |
24115572 | Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK. | 2013 Nov |
2 |
| 79 |
21684138 | Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. | 2012 May |
3 |
| 80 |
22142405 | The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment. | 2012 May |
2 |
| 81 |
22900074 | TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells. | 2012 |
3 |
| 82 |
21324906 | Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells. | 2011 Apr 15 |
5 |
| 83 |
21857081 | Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells. | 2011 |
1 |
| 84 |
19910452 | Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells. | 2010 Feb |
1 |
| 85 |
20106899 | Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity. | 2010 May |
1 |
| 86 |
19258036 | Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells. | 2009 Jul |
2 |
| 87 |
19471112 | Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity. | 2009 |
2 |
| 88 |
19723115 | Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells. | 2009 Aug |
2 |
| 89 |
19787270 | Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses. | 2009 Nov |
2 |
| 90 |
18093981 | A sensitive flow cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells. | 2008 Feb 29 |
1 |
| 91 |
18249159 | ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses. | 2008 Mar 1 |
5 |
| 92 |
18331824 | Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. | 2008 May 16 |
2 |
| 93 |
18372076 | Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway. | 2008 Oct |
3 |
| 94 |
18391982 | Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. | 2008 Jul 31 |
2 |
| 95 |
18726921 | High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma. | 2008 Dec |
1 |
| 96 |
17283157 | Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species. | 2007 Feb 1 |
1 |
| 97 |
17409444 | Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. | 2007 Apr 1 |
1 |
| 98 |
17418561 | Piperine protects cisplatin-induced apoptosis via heme oxygenase-1 induction in auditory cells. | 2007 Sep |
1 |
| 99 |
17586463 | Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways. | 2007 Aug 17 |
3 |
| 100 |
16462770 | MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. | 2006 Jun 1 |
3 |